
The 2024-2025 updated COVID-19 vaccine containing the Omicron JN.1 lineage did not increase the risk of 29 adverse events of special interest.

The 2024-2025 updated COVID-19 vaccine containing the Omicron JN.1 lineage did not increase the risk of 29 adverse events of special interest.

Among patients with cirrhosis receiving diuretic therapy, researchers explore the association between SGLT-2 inhibitors and the risk of serious liver outcomes.

Michael Murphy, PharmD, MBA, joined Drug Topics to present his ideas for correcting the growing issue of pharmacy deserts and unprecedented closures across the country.

Kristen Jones, PharmD, discusses leadership strategies in pharmacy management that prioritize emotional intelligence and communication for enhanced team performance and patient care.

Pharmacy professionals evolve into strategic leaders, mastering emotional intelligence and management skills to navigate complex workplace dynamics and enhance patient care.


The pharmacy profession is being reshaped by new roles, shifting expectations, and increasing pressure on workplace conditions.

Senators Warner and Thune reintroduced the ECAPS legislation improving both seniors’ access to care and pharmacists’ ability to get reimbursed for clinical services.

Researchers explored how the GLP-1 medications semaglutide and tirzepatide impact incidence rates in a variety of health-related outcomes.

A study found that the MyMenoplan website significantly improved users’ menopause knowledge, treatment awareness, and decision-making confidence.

Secretary of US Health and Human Services Robert F. Kennedy Jr also approved all recommendations issued from the April ACIP meeting.

LEO Pharma’s topical medication was shown to be safe and effective in adult patients with moderate-to-severe hand eczema.

The risk of untreated depression for pregnant women can cause adverse outcomes, which can include relapse in mood symptoms, suicide, and overdose death.

Women with premature ovarian insufficiency experience a high prevalence of depressive symptoms, highlighting the need for comprehensive, multidisciplinary care.

Amid uncertainty about the best factors for measuring and defining pharmacy deserts, researchers explored the impacts of drive time and inequities in pharmacy access.

Pharmacists can improve insulin safety and adherence by combining in-person counseling with practical tools, regular check-ins, and proactive education.

Michael Murphy, PharmD, MBA, provided insights on his research regarding pharmacy deserts, who they impact the most, and the methods needed to improve them in the US.

Addressing harassment, strengthening leadership, and involving frontline pharmacy staff in decision-making are key steps toward a healthier, more supportive work environment.

Flu vaccination significantly reduces illness in vaccinated and unvaccinated individuals, highlighting its importance in public health strategies.

From 2008 to 2023, the relative increase of pediatric patients with obesity classes 4 to 5 was 253.1%.

With an emphasis on the factors that differentiate the future roles of pharmacists, researchers sought to better understand the career intentions of pharmacy students.

Pharmacists play a key role in monitoring insulin use by addressing dosing, storage, and symptom management through regular, supportive patient check-ins.

The FDA approves Kirsty, an interchangeable biosimilar insulin, enhancing diabetes treatment options and accessibility for patients.

Community pharmacists play a crucial role in helping patients start insulin with confidence through education, emotional support, and hands-on guidance.

Using the Q Methodology to account for subjectivity in responses, pharmacists self-identified their professional identities.

New study data reveal the waning effectiveness of 2023-2024 COVID-19 vaccines, highlighting the need for ongoing vaccinations and pharmacist involvement.

Older adults with insomnia face heightened depression risks during inflammation, highlighting the need for targeted monitoring and treatment strategies.

In the researchers’ exploration of post-ICU nutritional care, they detailed the clinical pharmacist’s role and provided insights into how this role may evolve in the future.

Emphasizing the pharmacist’s essential role, researchers explored the causes, consequences, and clinical implications of polypharmacy.

This year’s conference is taking place from August 1 to 4 in Cincinnati, Ohio.